New generation breast cancer cell lines developed from patient-derived xenografts

BACKGROUND: Breast cancer is a highly heterogeneous disease characterized by multiple histologic and molecular subtypes. While a myriad of breast cancer cell lines have been developed over the past 60 years, estrogen receptor alpha (ER)+ disease and some mutations associated with this subtype remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Finlay-Schultz, Jessica, Jacobsen, Britta M., Riley, Duncan, Paul, Kiran V., Turner, Scott, Ferreira-Gonzalez, Andrea, Harrell, J. Chuck, Kabos, Peter, Sartorius, Carol A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310532/
https://www.ncbi.nlm.nih.gov/pubmed/32576280
http://dx.doi.org/10.1186/s13058-020-01300-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310532/
https://www.ncbi.nlm.nih.gov/pubmed/32576280
http://dx.doi.org/10.1186/s13058-020-01300-y

Ejemplares similares